Prodia Diagnostic Line is trading at IDR 126.00, down 6.67%, amid broad Indonesian selling as investors reacted to MSCI’s proposal to reclassify the country from emerging-market to standalone status.
- Reuters reported Indonesian equities faced a record two-day rout; the benchmark fell more than 5% on October 19.
- No distinct company-specific announcement explaining the decline was identified; available evidence points to country-wide market pressure.